Marburg virus vaccine (adenoviral vector) (GenPhar)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMarburg virus vaccine (adenoviral vector) (GenPhar)

Drug Alias NamecAdVax-MARVadenoviral vector based trivalent Marburg vaccine (GenPhar)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMarburg Virus Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenphar

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenphar

Active IndicationsN/A

Inactive IndicationsMarburg Virus Disease

Other Information

ATC CodeN/A